Document Detail

Diosgenin interferes coronary vasoconstriction and inhibits osteochondrogenic transdifferentiation of aortic VSMC in CRF rats.
MedLine Citation:
PMID:  24742379     Owner:  NLM     Status:  Publisher    
Cardiovascular dysfunction and vascular calcification is the leading cause of death in chronic renal failure (CRF) patients. This study was designed to evaluate the effect of diosgenin on coronary flow resistance and to address the question whether the previously proven antivascular calcification potential of diosgenin is associated or not with the osteochondrogenic transdifferentiation of vascular smooth muscle cells (VSMC). In this study, CRF in Wistar rats was induced by fed with 0.75% adenine and diosgenin was treated everyday at the dose of 40 mg/kg. Langendorff based isolated heart protocol was employed to analyze the coronary flow resistance. Western blot method was used to explore the phosphorylation dynamics of endothelial nitric oxide synthase (eNOS) at the serine 1177 residue. In addition, cardiac nitric oxide metabolites level also assessed. Quantitative expression of VSMC and osteochondrogenic markers was also evaluated. Antioxidant potential of diosgenin was studied in vitro. The outcome of the present study explores that diosgenin treatment significantly improves the coronary resistance and increased the nitric oxide metabolites level compared with CRF. Further, diosgenin increases the phosphorylation of eNOS (peNOS ser1177). Moreover, diosgenin reduced the aortic expression of osteochondrogenic markers and improved the VSMC phenotype components. Further, diosgenin shows concentration dependent antioxidant potential. In conclusion, this study have proven that diosgenin have enough potential to improve the coronary function and interfere the osteochondrogenic transdifferentiation program of aortic VSMC which supports its antivascular calcification potential.
Jeganathan Manivannan; Janakiraman Shanthakumar; Pandiyan Arunagiri; Boobalan Raja; Elumalai Balamurugan
Related Documents :
687489 - Use of 129caesium, 99tcm stannous pyrophosphate, and a combination of the two in the as...
6508969 - Behçet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis.
1678029 - High breath pentane concentrations during acute myocardial infarction.
1997639 - Prostacyclin production in myocardial infarction in the acute phase and during follow-up.
19675819 - Successful use of a guide wire to engage an occluded vessel following failure of conven...
1818429 - Role of domperidone in improving intestinal activity in acute myocardial infarction pat...
7074799 - Hypothermic coronary venous phased retroperfusion: a closed-chest treatment of acute re...
16019089 - Successful radiofrequency catheter ablation of idiopathic ventricular fibrillation pres...
165909 - Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-15
Journal Detail:
Title:  Biochimie     Volume:  -     ISSN:  1638-6183     ISO Abbreviation:  Biochimie     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1264604     Medline TA:  Biochimie     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Isodeoxyelephantopin from Elephantopus scaber (Didancao) induces cell cycle arrest and caspase-3-med...
Next Document:  Glutathione modulation during sensitization as well as challenge phase regulates airway reactivity a...